ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 65 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $0 | -100.0% | 568 | +7.8% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | -50.0% | 527 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | – | 527 | +584.4% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 77 | -99.0% | 0.00% | – |
Q1 2016 | $38,000 | +18.8% | 7,973 | 0.0% | 0.00% | – |
Q4 2015 | $32,000 | +68.4% | 7,973 | +58.2% | 0.00% | – |
Q3 2015 | $19,000 | -17.4% | 5,041 | 0.0% | 0.00% | – |
Q2 2015 | $23,000 | -42.5% | 5,041 | -16.6% | 0.00% | – |
Q1 2015 | $40,000 | – | 6,041 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |